A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

NCT01625351 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Ewing Sarcoma
Gastrointestinal Tumor
Germ Cell Tumor
Hepatic Tumor
Lymphoma
Wilms Tumor
Rhabdoid Tumor
Clear Cell Carcinoma
Renal Cell Carcinoma
Melanoma
Neuroblastoma
Rhabdomyosarcoma
Non-rhabdomyosarcoma

Interventions

DRUG: alemtuzumab
DRUG: fludarabine
DRUG: sirolimus
DRUG: Busulfan
DRUG: melphalan
BIOLOGICAL: stem cells
DEVICE: CliniMACS

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]